This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Asking medical questions of AI with language spoken “in the wild”—meaning with LLM prompts from everyday consumers—brings back answers with decidedly mediocre accuracy, a new study shows.
A team of healthcare scholars is making U.S. states an offer they hope the border-defined polities won’t refuse: If you’ll pay for the reinvention of primary care, we’ll help sell the public on the rightness of measured, state-level efforts to preserve the profession.
Teladoc, the popular telehealth platform, will provide urgent care, dermatology and nutrition support through Walmart’s existing virtual patient care platform. The companies made the announcement Thursday.
As a class-action lawsuit gets rolling in California over the use of ambient AI in healthcare, a national law firm is drawing takeaways for hospitals and other provider organizations. Makes sense: All AI-equipped providers are potential targets for similar litigation now.
The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium.
Researchers think this new technique could be beneficial for patients presenting with both severe symptomatic aortic stenosis and chronic kidney disease.
American war veterans take their own lives at a rate much higher than the civilian average. Might AI help formulate some sort of solution? The week of Independence Day seems a fitting time to consider the possibility.
The algorithm, developed using data from more than 7,00 chest pain patients, performed better than multiple techniques currently used to evaluate cardiac events.
The primary concern is that sterilization facilities and healthcare providers would not have enough time to adapt to the proposal. Devices impacted would include pacemakers, angioplasty balloons and catheters, just to name a few.
The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin.